Safety, Tolerability and Pharmacokinetics of Tiotropium in Cystic Fibrosis Patients

NCT02172534 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

113

Enrollment

INDUSTRY

Sponsor class

Conditions

Cystic Fibrosis

Interventions

DRUG: Tiotropium bromide low
DRUG: Tiotropium bromide medium
DRUG: Tiotropium bromide high
DRUG: Placebo

Sponsor

Boehringer Ingelheim